Telesis Bio (TBIO) Competitors $0.01 0.00 (0.00%) As of 05/23/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainSEC FilingsTrendsBuy This Stock TBIO vs. SMIT, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, and KEYSShould you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Schmitt Industries (SMIT), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), and Keysight Technologies (KEYS). These companies are all part of the "measuring and control equipment" industry. Telesis Bio vs. Schmitt Industries Spectaire ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Schmitt Industries (NASDAQ:SMIT) and Telesis Bio (NASDAQ:TBIO) are both small-cap industrials companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, analyst recommendations, community ranking, earnings, valuation and profitability. Which has higher earnings and valuation, SMIT or TBIO? Schmitt Industries has higher earnings, but lower revenue than Telesis Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSchmitt Industries$9.89M0.01-$3.28MN/AN/ATelesis Bio$225.09M0.00-$47.72M-$28.200.00 Do insiders & institutionals have more ownership in SMIT or TBIO? 37.6% of Telesis Bio shares are owned by institutional investors. 17.1% of Schmitt Industries shares are owned by company insiders. Comparatively, 24.5% of Telesis Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in SMIT or TBIO? Schmitt Industries received 85 more outperform votes than Telesis Bio when rated by MarketBeat users. Likewise, 55.29% of users gave Schmitt Industries an outperform vote while only 52.94% of users gave Telesis Bio an outperform vote. CompanyUnderperformOutperformSchmitt IndustriesOutperform Votes9455.29% Underperform Votes7644.71% Telesis BioOutperform Votes952.94% Underperform Votes847.06% Is SMIT or TBIO more profitable? Schmitt Industries has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets Schmitt IndustriesN/A N/A N/A Telesis Bio -336.59%N/A -61.89% Does the media prefer SMIT or TBIO? In the previous week, Schmitt Industries' average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score. Company Overall Sentiment Schmitt Industries Neutral Telesis Bio Neutral Which has more risk and volatility, SMIT or TBIO? Schmitt Industries has a beta of -0.31, indicating that its stock price is 131% less volatile than the S&P 500. Comparatively, Telesis Bio has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. SummarySchmitt Industries beats Telesis Bio on 6 of the 10 factors compared between the two stocks. Get Telesis Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TBIO vs. The Competition Export to ExcelMetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$21,000.00$4.37B$5.39B$8.42BDividend YieldN/A0.58%5.28%4.15%P/E Ratio0.0026.9927.1919.79Price / Sales0.003.81395.72137.25Price / CashN/A36.1638.3234.64Price / Book0.081.566.804.55Net Income-$47.72M-$84.30M$3.24B$248.31M7 Day PerformanceN/A0.12%-0.14%-0.21%1 Month PerformanceN/A4.07%7.74%9.03%1 Year PerformanceN/A-19.06%19.21%8.57% Telesis Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TBIOTelesis BioN/A$0.01flatN/A-99.7%$21,000.00$225.09M0.00200Upcoming EarningsSMITSchmitt IndustriesN/A$0.02flatN/AN/A$72,000.00$9.89M0.00160SPECSpectaireN/A$0.00flatN/A-99.3%$39,000.00N/A0.008THMOThermoGenesisN/AN/AN/AN/A$1,000.00$9.61M0.0040HTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.04-10.9%N/A-52.9%$0.00N/A0.003PRENWPrenetics GlobalN/A$0.01+10.0%N/AN/A$0.00$30.62M0.001Gap UpQSIAWQuantum-SiN/A$0.42-8.9%N/A+396.2%$0.00$3.06M0.00150Gap DownSMAPWSportsMap Tech AcquisitionN/A$0.05+11.1%N/A+12.8%$0.00N/A0.00N/AGap UpTTTrane Technologies4.1526 of 5 stars$431.02+0.4%$425.47-1.3%+25.4%$96.13B$20.31B38.3139,000Positive NewsAnalyst RevisionKEYSKeysight Technologies4.4791 of 5 stars$162.76-1.6%$181.33+11.4%+11.2%$28.13B$5.02B46.5015,000Earnings ReportGap Down Related Companies and Tools Related Companies Schmitt Industries Competitors Spectaire Competitors ThermoGenesis Competitors HTG Molecular Diagnostics Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors Trane Technologies Competitors Keysight Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TBIO) was last updated on 5/27/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telesis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TBIO Stock Free TBIO Stock Alerts